Cargando…

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections

Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection...

Descripción completa

Detalles Bibliográficos
Autores principales: Siedner, Mark J., Boucau, Julie, Gilbert, Rebecca F., Uddin, Rockib, Luu, Jonathan, Haneuse, Sebastien, Vyas, Tammy, Reynolds, Zahra, Iyer, Surabhi, Chamberlin, Grace C., Goldstein, Robert H., North, Crystal M., Sacks, Chana A., Regan, James, Flynn, James P., Choudhary, Manish C., Vyas, Jatin M., Barczak, Amy K., Lemieux, Jacob E., Li, Jonathan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855795/
https://www.ncbi.nlm.nih.gov/pubmed/34871181
http://dx.doi.org/10.1172/jci.insight.155483
_version_ 1784653716200095744
author Siedner, Mark J.
Boucau, Julie
Gilbert, Rebecca F.
Uddin, Rockib
Luu, Jonathan
Haneuse, Sebastien
Vyas, Tammy
Reynolds, Zahra
Iyer, Surabhi
Chamberlin, Grace C.
Goldstein, Robert H.
North, Crystal M.
Sacks, Chana A.
Regan, James
Flynn, James P.
Choudhary, Manish C.
Vyas, Jatin M.
Barczak, Amy K.
Lemieux, Jacob E.
Li, Jonathan Z.
author_facet Siedner, Mark J.
Boucau, Julie
Gilbert, Rebecca F.
Uddin, Rockib
Luu, Jonathan
Haneuse, Sebastien
Vyas, Tammy
Reynolds, Zahra
Iyer, Surabhi
Chamberlin, Grace C.
Goldstein, Robert H.
North, Crystal M.
Sacks, Chana A.
Regan, James
Flynn, James P.
Choudhary, Manish C.
Vyas, Jatin M.
Barczak, Amy K.
Lemieux, Jacob E.
Li, Jonathan Z.
author_sort Siedner, Mark J.
collection PubMed
description Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections.
format Online
Article
Text
id pubmed-8855795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-88557952022-02-22 Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections Siedner, Mark J. Boucau, Julie Gilbert, Rebecca F. Uddin, Rockib Luu, Jonathan Haneuse, Sebastien Vyas, Tammy Reynolds, Zahra Iyer, Surabhi Chamberlin, Grace C. Goldstein, Robert H. North, Crystal M. Sacks, Chana A. Regan, James Flynn, James P. Choudhary, Manish C. Vyas, Jatin M. Barczak, Amy K. Lemieux, Jacob E. Li, Jonathan Z. JCI Insight Research Article Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections. American Society for Clinical Investigation 2022-01-25 /pmc/articles/PMC8855795/ /pubmed/34871181 http://dx.doi.org/10.1172/jci.insight.155483 Text en © 2022 Siedner et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Siedner, Mark J.
Boucau, Julie
Gilbert, Rebecca F.
Uddin, Rockib
Luu, Jonathan
Haneuse, Sebastien
Vyas, Tammy
Reynolds, Zahra
Iyer, Surabhi
Chamberlin, Grace C.
Goldstein, Robert H.
North, Crystal M.
Sacks, Chana A.
Regan, James
Flynn, James P.
Choudhary, Manish C.
Vyas, Jatin M.
Barczak, Amy K.
Lemieux, Jacob E.
Li, Jonathan Z.
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title_full Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title_fullStr Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title_full_unstemmed Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title_short Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
title_sort duration of viral shedding and culture positivity with postvaccination sars-cov-2 delta variant infections
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855795/
https://www.ncbi.nlm.nih.gov/pubmed/34871181
http://dx.doi.org/10.1172/jci.insight.155483
work_keys_str_mv AT siednermarkj durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT boucaujulie durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT gilbertrebeccaf durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT uddinrockib durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT luujonathan durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT haneusesebastien durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT vyastammy durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT reynoldszahra durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT iyersurabhi durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT chamberlingracec durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT goldsteinroberth durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT northcrystalm durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT sackschanaa durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT reganjames durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT flynnjamesp durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT choudharymanishc durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT vyasjatinm durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT barczakamyk durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT lemieuxjacobe durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections
AT lijonathanz durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections